Galderma Group AG
Patient Education in Adherence on Acne (PEAce)
- Conditions
- Interventions
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 97
- Registration Number
- NCT02307266
- Locations
- 🇬🇧
Burbage Surgery, Burbage, United Kingdom
🇬🇧Swan Lane Medical Centre, Bolton, United Kingdom
🇬🇧South Axholme Practice, Epworth, United Kingdom
Effect of CD07805/47 Gel in Rosacea Flushing
- Conditions
- Interventions
- First Posted Date
- 2014-11-24
- Last Posted Date
- 2016-10-20
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 34
- Registration Number
- NCT02300129
- Locations
- 🇩🇪
Galderma Investigational site, Hamburg, Germany
Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment
- Conditions
- Interventions
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 65
- Registration Number
- NCT02297516
- Locations
- 🇧🇷
Brazilian Center for Studies in Dermatology, Porto Alegre, Brazil
🇫🇷Mediti Center, Paris, Antibes, France
🇫🇷Centre Medical Saint-Jean, Arras, France
Safety and Efficacy of Treatment With Azzalure, Restylane/Emervel Filler and Restylane Skinbooster
- Conditions
- Interventions
- First Posted Date
- 2014-11-21
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 61
- Registration Number
- NCT02297503
- Locations
- 🇸🇪
Akademikliniken, Stockholm, Sweden
🇫🇷Centre Medical Saint-Jean, Arras, France
🇫🇷Mediti Center, Paris, Antibes, France
Assessment of the Rosacea Prevalence in the General Population
- Conditions
- First Posted Date
- 2014-11-17
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 6000
- Registration Number
- NCT02292797
Rosacea Prevalence in General Population - Pilot Study
- First Posted Date
- 2014-11-17
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 120
- Registration Number
- NCT02292836
- Locations
- 🇸🇪
Mats BERG, Eskilstuna, Sweden
🇨🇦Jerry TAN, Windsor, Ontario, Canada
Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.
- Conditions
- Interventions
- First Posted Date
- 2014-09-29
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 20
- Registration Number
- NCT02251756
Mirvaso in Use Study
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 205
- Registration Number
- NCT02249065
- Locations
- 🇺🇸
Redwood Dermatology Research, Santa Rosa, California, United States
🇺🇸Manhattan Dermatology and Cosmetic Surgery, New York, New York, United States
🇺🇸DermDox Centers for Dermatology, Hazleton, Pennsylvania, United States
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 28
- Registration Number
- NCT02249104
- Locations
- 🇺🇸
Pflugerville Dermatology Clinical Research, Pflugerville, Texas, United States
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
- Conditions
- Interventions
- First Posted Date
- 2014-09-10
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 359
- Registration Number
- NCT02236312
- Locations
- 🇺🇸
Private practice, Salt Lake City, Utah, United States